Abstract:BACKGROUND: CD4(+)CD25(+) regulatory T cells (Tregs), a heterogeneous population, were enrichment in tumor mass and played an important role in modulating anti-tumor immunity. Recently, we reported a Treg subset, CCR6(+) Tregs but not CCR6(-)Tregs, were enriched in tumor mass and closely related to poor prognosis of breast cancer patients. However, the underlying mechanism remains elusive. Here, we carefully evaluate the enrichment of CCR6(+)Tregs in tumor mass during progression of breast cancer and explore its possible mechanism. METHODOLOGY/PRINCIPAL FINDINGS: The frequency of CCR6(+)Tregs in tumor infiltrating lymphocytes (TILs ) was analyzed at early stage and at late stage of tumor in a murine breast cancer model by FACS respectively. The expansion of CCR6(+)Tregs and their CCR6(-) counterpart in tumor mass were determined by BrdU incorporation assay. The effect and its possible mechanism of tumor-resident antigen presenting cells (APCs) on the proliferation of CCR6(+)Tregs also were evaluated. The role of local expansion of CCR6(+)Tregs in their enrichment and suppression in vivo also was evaluated in adoptive cell transfer assay. We found that the prior enrichment of CCR6(+)Tregs but not CCR6(-)Tregs in tumor mass during progression of murine breast cancer, which was dependent on the dominant proliferation of CCR6(+) Tregs in situ. Further study demonstrated that tumor-resident DCs triggered the proliferation of CCR6(+)Treg cells in TGF-β dependent manner. Adoptive transfer of CCR6(+)Tregs was found to potently inhibit the function of CD8(+)T cells in vivo, which was dependent on their proliferation and subsequently enrichment in tumor mass. CONCLUSIONS/SIGNIFICANCE: Our finding suggested that CCR6(+) Tregs, a distinct subset of Tregs, exert its predominant suppressive role in tumor immunity through prior in situ expansion, which might ultimately provide helpful thoughts for the designing of Treg-based immunotherapy for tumor in the future.

Aire-Dependent Thymic Development of Tumor-Associated Regulatory T Cells

CD39+ Regulatory T Cells Suppress Generation and Differentiation of Th17 Cells in Human Malignant Pleural Effusion Via a LAP-dependent Mechanism

Shaping the repertoire of tumor-infiltrating effector and regulatory T cells

Induction of anergic or regulatory tumor-specific CD4+ T cells in the tumor-draining lymph node

Regulatory T‐cell development in the tumor microenvironment

Regulatory T Cells: Barriers of Immune Infiltration Into the Tumor Microenvironment

Aire-dependent thymic FoxP3+ regulatory T cells in Type 1 Diabetes

Regulatory T cells in tumor immunity

Peripheral-derived regulatory T cells contribute to tumor-mediated immune suppression in a nonredundant manner

Tracking of individual autoreactive and regulatory T cells in Aire deficient TCR "mini" Foxp3-GFP mice (48.16)

The role of T helper 17 and regulatory T cells in tumor microenvironment

In Situ Prior Proliferation of CD4+ CCR6+ Regulatory T Cells Facilitated by TGF-β Secreting DCs is Crucial for Their Enrichment and Suppression in Tumor Immunity.

Aire and T cell development

Precise Spatiotemporal Interruption of Regulatory T-cell-Mediated CD8(+) T-cell Suppression Leads to Tumor Immunity

Intratumoral regulatory T cells: markers, subsets and their impact on anti‐tumor immunity

AIRE illuminates the feature of medullary thymic epithelial cells in thymic carcinoma

Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells

Tumor-secreted Mir-214 Induces Regulatory T Cells: a Major Link Between Immune Evasion and Tumor Growth

Regulatory T Cells in the Tumor Microenvironment and Cancer Progression: Role and Therapeutic Targeting

Recirculating Foxp3+ regulatory T cells are restimulated in the thymus under Aire control

Aire Regulates the Transfer of Antigen from Mtecs to Dendritic Cells for Induction of Thymic Tolerance.